These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 27818949)
41. Early Prediction of Tumor Response to Treatment: Preclinical Validation of 99mTc-Duramycin. Elvas F; Vangestel C; Pak K; Vermeulen P; Gray B; Stroobants S; Staelens S; Wyffels L J Nucl Med; 2016 May; 57(5):805-11. PubMed ID: 26837335 [TBL] [Abstract][Full Text] [Related]
42. Comparison of the Accuracy of FMT/CT and PET/MRI for the Assessment of Antibody Biodistribution in Squamous Cell Carcinoma Xenografts. Hage C; Gremse F; Griessinger CM; Maurer A; Hoffmann SHL; Osl F; Pichler BJ; Kiessling F; Scheuer W; Pöschinger T J Nucl Med; 2018 Jan; 59(1):44-50. PubMed ID: 28848038 [TBL] [Abstract][Full Text] [Related]
43. Polyethylene glycol-conjugated HER2-targeted peptides as a nuclear imaging probe for HER2-overexpressed gastric cancer detection in vivo. Guan SS; Wu CT; Chiu CY; Luo TY; Wu JY; Liao TZ; Liu SH J Transl Med; 2018 Jun; 16(1):168. PubMed ID: 29921305 [TBL] [Abstract][Full Text] [Related]
44. Development of a Novel Imaging Agent for Determining Albumin Uptake in Solid Tumors. Daum S; Magnusson JP; Pes L; Garcia Fernandez J; Chercheja S; Medda F; Nollmann FI; Koester SD; Perez Galan P; Warnecke A; Abu Ajaj K; Kratz F Nucl Med Mol Imaging; 2019 Jun; 53(3):189-198. PubMed ID: 31231439 [TBL] [Abstract][Full Text] [Related]
45. Feasibility of poly(ethylene glycol) derivatives as diagnostic drug carriers for tumor imaging. Kanazaki K; Sano K; Makino A; Yamauchi F; Takahashi A; Homma T; Ono M; Saji H J Control Release; 2016 Mar; 226():115-23. PubMed ID: 26869546 [TBL] [Abstract][Full Text] [Related]
46. Near-infrared fluorescence imaging of lymph nodes using a new enzyme sensing activatable macromolecular optical probe. Wunderbaldinger P; Turetschek K; Bremer C Eur Radiol; 2003 Sep; 13(9):2206-11. PubMed ID: 12802615 [TBL] [Abstract][Full Text] [Related]
47. Detection of Micrometastases Using SPECT/Fluorescence Dual-Modality Imaging in a CEA-Expressing Tumor Model. Hekman MCH; Rijpkema M; Bos DL; Oosterwijk E; Goldenberg DM; Mulders PFA; Boerman OC J Nucl Med; 2017 May; 58(5):706-710. PubMed ID: 28126888 [TBL] [Abstract][Full Text] [Related]
48. Hydrophobic insertion-based engineering of tumor cell-derived exosomes for SPECT/NIRF imaging of colon cancer. Jing B; Gai Y; Qian R; Liu Z; Zhu Z; Gao Y; Lan X; An R J Nanobiotechnology; 2021 Jan; 19(1):7. PubMed ID: 33407513 [TBL] [Abstract][Full Text] [Related]
49. Integrin α6 Targeted Near Infrared Fluorescent Imaging and Photoacoustic Imaging of Hepatocellular Carcinoma in Mice. Lin YZ; Wu Y; Cao DH; Peng YJ; Deng J; Lin WJ; Si-Tu MY; Zhuo L; Chen JM; Lei MX; Liu RB; Zhang WG; Li JJ; Yang XC; Feng GK J Clin Transl Hepatol; 2023 Feb; 11(1):110-117. PubMed ID: 36406330 [TBL] [Abstract][Full Text] [Related]
50. Extracellular vesicles-based pre-targeting strategy enables multi-modal imaging of orthotopic colon cancer and image-guided surgery. Jing B; Qian R; Jiang D; Gai Y; Liu Z; Guo F; Ren S; Gao Y; Lan X; An R J Nanobiotechnology; 2021 May; 19(1):151. PubMed ID: 34022897 [TBL] [Abstract][Full Text] [Related]
51. Molecular imaging of fibrin deposition in deep vein thrombosis using fibrin-targeted near-infrared fluorescence. Hara T; Bhayana B; Thompson B; Kessinger CW; Khatri A; McCarthy JR; Weissleder R; Lin CP; Tearney GJ; Jaffer FA JACC Cardiovasc Imaging; 2012 Jun; 5(6):607-15. PubMed ID: 22698530 [TBL] [Abstract][Full Text] [Related]
52. Application of near-infrared fluorescence imaging using a polymeric nanoparticle-based probe for the diagnosis and therapeutic monitoring of colon cancer. Yoon SM; Myung SJ; Kim IW; Do EJ; Ye BD; Ryu JH; Park K; Kim K; Kwon IC; Kim MJ; Moon DH; Yang DH; Kim KJ; Byeon JS; Yang SK; Kim JH Dig Dis Sci; 2011 Oct; 56(10):3005-13. PubMed ID: 21465144 [TBL] [Abstract][Full Text] [Related]
53. Multimodal optical, X-ray CT, and SPECT imaging of a mouse model of breast cancer lung metastasis. Davison CA; Chapman SE; Sasser TA; Wathen C; Diener J; Schafer ZT; Leevy WM Curr Mol Med; 2013 Mar; 13(3):368-76. PubMed ID: 23331009 [TBL] [Abstract][Full Text] [Related]
54. Evaluating the Safety and Efficacy of a Topical Formulation Containing Epidermal Growth Factor, Tranexamic Acid, Vitamin C, Arbutin, Niacinamide and Other Ingredients as Hydroquinone 4% Alternatives to Improve Hyperpigmentation: A Prospective, Randomized, Controlled Split Face Study. Kalasho BD; Minokadeh A; Zhang-Nunes S; Zoumalan RA; Shemirani NL; Waldman AR; Pletzer V; Zoumalan CI J Cosmet Sci; 2020; 71(5):263-290. PubMed ID: 33022197 [TBL] [Abstract][Full Text] [Related]
55. Dual-Modality Immuno-PET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using an Anti-Prostate Stem Cell Antigen Cys-Diabody. Zettlitz KA; Tsai WK; Knowles SM; Kobayashi N; Donahue TR; Reiter RE; Wu AM J Nucl Med; 2018 Sep; 59(9):1398-1405. PubMed ID: 29602820 [TBL] [Abstract][Full Text] [Related]
56. Multifunctional Probe Based on "Chemical Antibody-Aptamer" for Noninvasive Detection of PD-L1 Expression in Cancer. Kong S; Liu Q; Chen Y; Liang B; Zhou Y; Lin J; Xie M; Qiu L Mol Pharm; 2024 Jan; 21(1):255-266. PubMed ID: 38093483 [TBL] [Abstract][Full Text] [Related]